Dr Neville Butcher
Dr

Neville Butcher

Email: 

Availability

Dr Neville Butcher is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Search Professor Neville Butcher’s works on UQ eSpace

66 works between 1996 and 2025
All (66) Journal Article (55) Book Chapter (4) Conference Publication (7)

61 - 66 of 66 works

2003

Journal Article

Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1)

Butcher, NJ, Arulpragasam, A, Pope, C and Minchin, RF (2003). Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). Biochemical Journal, 376 (2), 441-448. doi: 10.1042/BJ20030650

Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1)

2002

Journal Article

Pharmacogenetics of the arylamine N-acetyltransferases

Butcher, N. J., Boukouvala, S., Sim, E. and Minchin, R. F. (2002). Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics Journal, 2 (1), 30-42. doi: 10.1038/sj.tpj.6500053

Pharmacogenetics of the arylamine N-acetyltransferases

2000

Journal Article

Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells

Butcher, NJ, Ilett, KF and Minchin, RF (2000). Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Molecular Pharmacology, 57 (3), 468-473. doi: 10.1124/mol.57.3.468

Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells

2000

Journal Article

Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid

Butcher, NJ, Ilett, KF and Minchin, RF (2000). Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid. Biochemical Pharmacology, 60 (12), 1829-1836. doi: 10.1016/S0006-2952(00)00501-3

Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid

1998

Journal Article

Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by (CT)-T-190 and G(560)A mutations

Butcher, NJ, Ilett, KF and Minchin, RF (1998). Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by (CT)-T-190 and G(560)A mutations. Pharmacogenetics, 8 (1), 67-72. doi: 10.1097/00008571-199802000-00009

Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by (CT)-T-190 and G(560)A mutations

1996

Journal Article

Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro

Butcher, N.J., Minchin, R.F., Kadlubar, F.F. and llett , K.F. (1996). Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro. Carcinogenesis, 17 (4), 889-992. doi: 10.1093/carcin/17.4.889

Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro

Past funding

  • 2016 - 2019
    The pharmacology of sulfotransferase 4A1
    NHMRC Project Grant
    Open grant
  • 2015 - 2017
    Role of sirtuins in the regulation of the carcinogen metabolising arylamine N-acetyltransferases
    NHMRC Project Grant
    Open grant
  • 2012 - 2015
    Role of the drug metabolising enzyme arylamine N-acetyltransferase 1 in breast cancer
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    ResTeach 2011 0.1 FTE School of Biomedical Sciences
    UQ ResTeach
    Open grant
  • 2009 - 2012
    Pharmacological Targeting of Arylamine N-Acetyltransferase I
    NHMRC Project Grant
    Open grant

Availability

Dr Neville Butcher is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Charaterisation of ion channels as pattern recognition receptors for acidosis and potential anti-inflammatory targets.

    Associate Advisor

    Other advisors: Dr Nemat Khan, Dr Lachlan Rash

  • Doctor Philosophy

    Developing novel acid-sensing ion channel inhibitors as neuroprotective leads and diagnostic agents for multiple sclerosis.

    Associate Advisor

    Other advisors: Dr Nemat Khan, Dr Lachlan Rash

  • Doctor Philosophy

    Developing novel acid-sensing ion channel inhibitors as neuroprotective leads and diagnostic agents for multiple sclerosis.

    Associate Advisor

    Other advisors: Dr Nemat Khan, Dr Lachlan Rash

  • Doctor Philosophy

    Understanding the role acid-sensing ion channels in disease progression and pain associated with neuroinflammatory conditions.

    Associate Advisor

    Other advisors: Emeritus Professor Maree Smith, Dr Nemat Khan, Dr Lachlan Rash

  • Doctor Philosophy

    Inhalable nanoparticle-based gene delivery system for cystic fibrosis

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Associate Professor Lisa Kaminskas

Completed supervision

Enquiries

For media enquiries about Dr Neville Butcher's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au